This week, USP officially launched a public database of information collected on the quality of drugs from 8,700 records of tested samples from Ghana, Laos, Vietnam, Cambodia, the Philippines, Thailand, Peru, Guyana, and Columbia. The database is part of the USAID-supported Promoting the Quality of Medicines (PQM) program
The fight against drug counterfeiting is one of endless challenges and, increasingly, proven victories. One recent triumph has been that, with help from the Promoting the Quality of Medicines (PQM) program, Cambodia has reduced the number of its illegal pharmacies by 65% and has taken great strides in managing its...
The press release has not gone out yet, but USP has posted on its web site (and Tweeted, which is how we found out) that its revised standards for elemental impurities are available for public comment. The standards will be open for industry feedback through next spring.
At the USP science meeting in Toronto, I met Janeen Skutnik of Pfizer, currently chair of IPEC Americas, and former IPEC chair, Colorcon's David Schonecker. (Also met incoming chair, William Dale Carter of JM Huber, who will start his new role next year).
I spent the first part of this week in Toronto, Canada (light years away from the staid, dull town I remember visiting as a kid----with rush hours that easily rival New York’s. I almost missed my flight home!) to attend USP’s annual science meeting.
Any crime covered by the press inspires a wave of copycats. So, it seems, the global heparin supply chain will have to be closely monitored for some time. Both 2-D NMR and capillary electrophoresis have been recognized as the best ways to assess the purity of heparin.
Ever see the old Abbott and Costello "who's on first" baseball routine? "I don't know" was on third base. Pharma is not the only industry that suffers from less-than-perfect supply chain risk management, as Juran Institute CEO Joe De Feo pointed out in a recent audio interview.